Accepted at 5:01 p.m. Oct, 05, 2023 by Cameron
Author: tjs2902
Co-authors: Cameron
Related Note: 1500235811939
Rationale for change

Why not just have the SGLT2 inhibitors be part of the card?? Makes no sense to queue the user that there are 2 classes of drugs when there really are three. I get that there's another card specific to SGLT2 Inhibitors, but I'd rather not have this card putting the false memory that there are only 2 major classes when there are really 3 associated with yeast infection.
Source: Other - Critical thinking

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step2_v12::!Shelf::ObGyn::no_dupes #AK_Step1_v12::#UWorld::Step::110 #AK_Step1_v12::#SketchyMicro::02_Fungi::03_Opportunistic_Fungal_Infections::01_Candida_albicans #AK_Step2_v12::#Subjects::Obstetrics_&_Gynecology::01_Gynecology::Vagina::Vaginitis::Candida #AK_Step2_v12::#Resources_by_rotation::ObGyn::uw::dorian #AK_Step1_v12::#FirstAid::03_Microbiology::03_Mycology::02_Opportunistic_fungal_infections #AK_Other::!AK_UpdateTags::step2PotentialDupes::ausername::ObGyn::02 #AK_Step2_v12::#OME_banner::Clinical::13_Gynecology #AK_Step2_v12::#SketchyOBGYN::05_Benign_Gynecology_&_Urogynecology::01_STIs_&_Other_GYN_Infections::01_Vulvovaginitis_DDx #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::06_Retired_Lessons::03_Metformin,_thiazolidinediones,_pramlintide,_SGLT2_inhibitors_[Retired_Video] #AK_Step1_v12::#NBME::31 #AK_Other::#AK_Original_Decks::Step_1::Lolnotacop::Bugs #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step2_v12::Original_decks::Dorian::obgyn::uw #AK_Step1_v12::#FirstAid::03_Microbiology::06_Systems::11_Common_vaginal_infections #AK_Step1_v12::#OME::PreClinical::Microbiology::Microbiology_4::Fungi::Fungi #AK_Step2_v12::#UWorld::Step::7005 #AK_Step2_v12::#OME::05_Obstetrics_and_Gynecology::01_Gynecology::01_Gynecology::04_Gynecologic_Infections #AK_Step1_v12::#UWorld::COMLEX::26393 #AK_Step1_v12::#UWorld::Step::15546 #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step2_v12::#SketchyIM::05_Endocrinology::01_Diabetes_Mellitus::02_Diabetes_Management #AK_Step2_v12::#Subjects::Microbiology::03_Fungi::03_Opportunistic_Mycoses::Candida_Albicans::Vulvovaginal_Candidiasis #AK_Step1_v12::#FirstAid::03_Microbiology::03_Mycology::02_Opportunistic_fungal_infections::01_Candida_albicans #AK_Step2_v12::#UWorld::COMLEX::101732 #AK_Step3_v12::#NBME::Form7::Section_2 #AK_Step2_v12::#Subjects::Microbiology::03_Fungi::03_Opportunistic_Mycoses::Candida_Albicans #AK_Step1_v12::#Pixorize::03_Pharmacology::07_Diabetes_Drugs_(New)::09_SGLT2_Inhibitors #AK_Step1_v12::#Physeo::06_Micro::03_Fungi::08_Candida_Albicans #AK_Step2_v12::#Resources_by_rotation::ObGyn::uw::zanki::female_repro_breast #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Reproductive::Vaginitis_ddx #AK_Step2_v12::Original_decks::Zanki_Step_2::ObGyn::Female_Repro_&_Breast #AK_Other::!AK_UpdateTags::AnKing_Image::AhmedA::Vaginitis_ddx #AK_Step1_v12::#UWorld::COMLEX::23224 #AK_Step1_v12::#Bootcamp::Dermatology::02_Infectious_Diseases_of_the_Skin::04_Candida #AK_Step1_v12::#Bootcamp::Microbiology::18_Opportunistic_Mycosis::03_Candida_Pathogenesis